Zhejiang Shapuaisi Pharmaceutical Hits Day High with Strong 10% Intraday Surge

Zhejiang Shapuaisi Pharmaceutical Co. has experienced a significant uptick in its stock performance, gaining 10.01% on March 18, 2026. The stock reached an intraday high of CNY 7.80, marking a notable achievement in a day where the broader China Shanghai Composite index only rose by 0.32%. Over the past week, Zhejiang Shapuaisi has shown a robust performance with an 8.18% increase, contrasting sharply with the Shanghai Composite's decline of 1.7%. In the context of longer-term performance, the stock has risen by 5.69% over the past month, while the Shanghai Composite has seen a slight decrease of 0.47%. Despite these recent gains, the company faces challenges, including a low Return on Capital Employed (ROCE) of 1.63% and a history of negative results over the last six quarters. The stock's performance over the past year has been less favorable compared to the market, with a return of just 1.76% against the Shanghai Composite's 22.49%. As a small-cap player in the pharmaceuticals and biotechnology sector, Zhejiang Shapuaisi continues to navigate a complex market landscape.